I could have sworn you posted to this very thread: Short term memory issues? Now that's just funny, clearly you don't know much about me OR macro!
I would start selling those, a quick emergency fed cut and or some kind relief on virus cases and those will be back right where you bought them.
There might be a coordinated rate cut across all centralbanks reducing rates and pumping trillions of dollars into the system but it wont be a fix to the economy, it will only create more headwinds moving forward but it might cause a quick short term powerful rally which everyone will probably end up selling anyway...this could be the first time in history you could fight the fed.
https://www.marketwatch.com/story/h...eaks-as-chinas-coronavirus-spreads-2020-01-22 However, investors have been attuned to updates on the spread of the disease. Historically, however, Wall Street’s reaction to such epidemics and fast-moving diseases is often short-lived. According to Dow Jones Market Data, the S&P 500 posted a gain of 14.59% after the first occurrence of SARS back in 2002-03, based on the end of month performance for the index in April, 2003. About 12 months after that point, the broad-market benchmark was up 20.76% (see attached table): Epidemic Month end 6-month % change of S&P 12-month % change of S&P HIV/AIDS June 1981 -0.3 -16.5 Pneumonic plague September 1994 8.2 26.3 SARS April 2003 14.59 20.76 Avian flu June 2006 11.66 18.36 Dengue Fever September 2006 6.36 14.29 Swine flu April 2009 18.72 35.96 Cholera November 2010 13.95 5.63 MERS May 2013 10.74 17.96 Ebola March 2014 5.34 10.44 Measles/Rubeola December 2014 0.20 -0.73 Zika January 2016 12.03 17.45 Measles/Rubeola June 2019 9.82% N/A —Source: Dow Jones Market Data SARS resulted in a total of about 8,100 people being sickened during the 2003 outbreak, with 774 people dying, according to data from WHO and the Centers for Disease Control and Prevention.